$11.20
-0.21-1.8%
Last update: Nov 4, 10:09 AM
Polyrizon Ltd (PLRZ) Stock Price, Quote, News & History
PLRZNASDAQ
Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention.
You can purchase shares of Polyrizon (NASDAQ:PLRZ) through any online brokerage.
Other companies in Polyrizon’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Polyrizon to provide a consensus price target.
The stock price for Polyrizon (NASDAQ: PLRZ) is $11.2 last updated November 4, 2026 at 10:09 AM EST.
There are no upcoming dividends for Polyrizon.
Polyrizon does not have any upcoming earnings scheduled.
There is no upcoming split for Polyrizon.
Polyrizon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also...
